REBECA RIVERA: Open Payments
NPI 1184113094 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 53 payments from 17 companies in 2025. Trend: 2023 $693 · 2024 $738 · 2025 $1,862
Food & beverage: $1,862
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 16 | $620 |
| Novo Nordisk Inc | 7 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $226 |
| Axsome Therapeutics, Inc. | 7 | $202 |
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| INTUITIVE SURGICAL, INC. | 1 | $103 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Dexcom, Inc. | 2 | $47 |
| Abbott Laboratories | 2 | $43 |
| Exact Sciences Corporation | 2 | $40 |
Products named: Korlym, CAPLYTA, Auvelity, Ozempic, BREZTRI, Da Vinci Surgical System, AUSTEDO XR, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
